The authors have no conflicts of interest to disclose.
Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus
Article first published online: 15 MAR 2011
© 2011 Wiley Periodicals, Inc.
Volume 24, Issue 2, pages 263–272, March/April 2011
How to Cite
Hansra, N. K. and Shinkai, K. (2011), Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus. Dermatologic Therapy, 24: 263–272. doi: 10.1111/j.1529-8019.2011.01402.x
Funding sources: None.
Reprints not available from authors.
No prior presentation.
- Issue published online: 15 MAR 2011
- Article first published online: 15 MAR 2011
- hospitalized patient;
- methicillin-resistant Staphylococcus aureus;
The clinical presentation of methicillin-resistant Staphylococcus aureus (MRSA) infection ranges from asymptomatic colonization to cutaneous and invasive involvement. This review discusses the cutaneous presentations of community-acquired MRSA (CA-MRSA) and hospital-acquired MRSA (HA-MRSA) that one may encounter in the hospital or outpatient setting. Cutaneous CA-MRSA and HA-MRSA are often clinically indistinguishable, although they have different epidemiologic profiles and virulence factors. Bacterial culture is necessary for diagnosis and guides treatment, as infection with CA-MRSA and HA-MRSA require distinct clinical management. Guidelines for surgical interventions and antibiotic treatment of CA-MRSA and HA-MRSA will be discussed. Strategies for MRSA decolonization and prevention of further spread will also be reviewed.